These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1671724)

  • 1. Clinical pharmacology of vasodilatory beta-blocking drugs.
    Shanks RG
    Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
    Perrone MH; Barrett JA
    Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
    Alvarez-Guerra M; Alda O; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.
    Opie LH
    Am J Cardiol; 1988 Feb; 61(5):8C-13C. PubMed ID: 2893535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilatory beta-blockers: systemic and regional hemodynamic effects.
    Frohlich ED
    Am Heart J; 1991 Mar; 121(3 Pt 2):1012-6; discussion 1016-7. PubMed ID: 1671725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol and the heart.
    Taylor SH
    Am J Cardiol; 1988 Feb; 61(5):34C-40C. PubMed ID: 2893532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasodilatory beta-adrenoceptor blockers on cardiovascular haemodynamics in anaesthetized rats.
    Takahashi H; Masaki H; Komiyama Y; Masuda M; Nishimura M
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):198-203. PubMed ID: 11906483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects.
    Kahonen M; Ylitalo R; Koobi T; Turjanmaa V; Ylitalo P
    Gen Pharmacol; 2000 Oct; 35(4):219-24. PubMed ID: 11827729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
    Taddei S; Pedrinelli R; Salvetti A
    Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 19. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.